Here’s a podcast starring Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across a wide spectrum of Diabetes populations, including older adults and those with renal impairment and associated co-morbidities.